Clinical Trials Browser

INDUSTRY × Dosage Forms × Gastrointestinal × Clear all

NCT05410535 2024-06-28

To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

Phase 4 Completed

Gastrointestinal

Stomach Neoplasms